These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22389087)

  • 1. Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
    Murray E; Bruno R; Brown J
    Hum Psychopharmacol; 2012 Mar; 27(2):226-34. PubMed ID: 22389087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model.
    Dickson C; Bruno R; Brown J
    Neuropsychobiology; 2009; 60(3-4):204-12. PubMed ID: 19893337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term ecstasy-related change in visual perception.
    Brown J; Edwards M; McKone E; Ward J
    Psychopharmacology (Berl); 2007 Aug; 193(3):437-46. PubMed ID: 17457578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of recreational MDMA 'ecstasy' use on global form processing.
    White C; Edwards M; Brown J; Bell J
    J Psychopharmacol; 2014 Nov; 28(11):1018-29. PubMed ID: 25142406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
    Roberts GM; Nestor L; Garavan H
    Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.
    Murphy PN; Erwin PG; Maciver L; Fisk JE; Larkin D; Wareing M; Montgomery C; Hilton J; Tames FJ; Bradley B; Yanulevitch K; Ralley R
    Hum Psychopharmacol; 2011 Oct; 26(7):460-9. PubMed ID: 21898599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations to global but not local motion processing in long-term ecstasy (MDMA) users.
    White C; Brown J; Edwards M
    Psychopharmacology (Berl); 2014 Jul; 231(13):2611-22. PubMed ID: 24441968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered visual perception in long-term ecstasy (MDMA) users.
    White C; Brown J; Edwards M
    Psychopharmacology (Berl); 2013 Sep; 229(1):155-65. PubMed ID: 23609769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
    Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB
    Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
    Fisk JE; Montgomery C; Wareing M; Murphy PN
    Hum Psychopharmacol; 2006 Aug; 21(6):355-66. PubMed ID: 16915582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.